Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

This study has been suspended.

Study NCT00469859 Information provided by National Cancer Institute (NCI)

First Received: May 3, 2007 Last Updated: October 7, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been suspended.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)